Assurance de qualité pour le cancer rectal – phase 2 ...

More documents

Recommendations

Info

102 PROCARE – phase 2 KCE reports 81Figure 23. Algorithm for QI 1114 (administrative database).All patientsN = 7074N = 1473c-staging = IVor cN=1 or cN=2or cT=3 or cT=4 ?TrueIncidence datebetween 01.02.2003and 31.12.2003 ?FalseN = 183FalseN = 673TrueN = 5601MissingN = 617TrueMOCwithin 6 monthsafter incidence date ?N = 435FalseN = 238PROPORTION OF PATIENTS WITH DOCUMENTED DISTANCEFROM THE ANAL VERGEMeasurement in prospective PROCARE database (Figure 24)In the hospital data section of the PROCARE data entry form, the variable ‘AD_V111’ ischecked if the patient underwent rectal surgery. Within this group of patients, thoseundergoing resection (i.e. endoscopic, LE/TEMS, radical resection) are selected usingvariables ‘SG_V168’, ‘SG_V210’, ‘SG_V216’ and ‘SG_V234’. The distance from the analverge is available from 3 variables: two before any treatment (‘SPR_V110’ and‘SPR_V112’) and one at surgery (‘SG_V110’, which can have another value than theprevious two variables because of neoadjuvant treatment). A fourth variable is availablein the pathology section (‘PT_V105’), but this was not used because it is often based oninaccurate information. Importantly, unavailability of the distance from the anal verge inthe PROCARE dataset does not necessarily mean that the distance was notdocumented, but that the distance was not registered.Measurement in coupled administrative databaseNo administrative code exists for the (documentation of the) distance from the analverge.
KCE Reports 81 PROCARE – phase 2 103Figure 24. Algorithm for QI 1211 (PROCARE database).All patientsN=1071SurgeryN=1058RadicalsurgeryN=1018Documented distancefrom anal vergeN=990 97,1%Surgery?Radicalsurgery?Distance from analverge filled out?No radicalsurgeryORRadical surgery=MISSINGN=40No documented distancefrom anal vergeN=28No surgeryN=13PROPORTION OF PATIENTS IN WHOM A CT OF THE LIVER ANDCT OR RX OF THE THORAX WAS PERFORMED BEFORE ANYTREATMENTMeasurement in prospective PROCARE databaseVariables ‘SPR_V141’ and ‘SPR_V143’ register the use of a CT scan or RX respectivelyfor the determination of the cM stage. However, no specification is given for theanatomic region of the CT or RX. Therefore, this QI is not measurable.Measurement in coupled administrative database (Figure 25)A nomenclature code exists for the performance of a CT, however withoutspecification of the anatomic region (Table 62). On the other hand, specific ICD-9-CMcodes exist for CT of the abdomen (not liver!) and thorax (Table 63). However, thesecodes are only available from the Technical Cell database (see 3.1.2.2), which is adatabase of coupled hospital registration data (i.e. no information on ambulatoryperformance of these tests). Importantly, coding of these procedures is not obligatory.Therefore, using these codes causes an important underestimation of the frequency ofthese tests.In order to identify if the imaging test was done before any treatment, the date of thefirst treatment (surgery, radiotherapy, chemotherapy) after diagnosis should be known(see algorithm). To identify if and when a patient underwent surgery, nomenclaturecodes (Table 64 and 65) or surgical ICD-9-CM codes (Table 66, 67 and 68) incombination with diagnostic ICD-9-CM codes (Table 69) were used. For radiotherapy,nomenclature codes were used (Table 70), since for only 12 patients ICD-9-CM codesrelated to radiotherapy (Table 71) were found. For chemotherapy, the CNK codes ofthe HIC database were used (Table 72). An important problem with the Technical Celldatabase is the absence of the exact date of the procedure.
Page 1 and 2:
Assurance de qualitépour le cancer
Page 3 and 4:
Assurance de qualité pour lecancer
Page 5 and 6:
KCE Reports 81B Cancer rectal - pha
Page 7:
KCE Reports 81B Cancer rectal - pha
Page 10 and 11:
vi Cancer rectal - phase 2 KCE Repo
Page 12 and 13:
2 PROCARE - phase 2 KCE reports 81A
Page 14 and 15:
4 PROCARE - phase 2 KCE reports 811
Page 16 and 17:
6 PROCARE - phase 2 KCE reports 81F
Page 19 and 20:
KCE Reports 81 PROCARE - phase 2 92
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62: KCE Reports 81 PROCARE - phase 2 51
Page 87 and 88: KCE Reports 81 PROCARE - Phase 2 77
Page 111: KCE Reports 81 PROCARE - phase 2 10
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169:
Page 172 and 173:
Dépôt légal : D/2008/10.273/39
Page 174 and 175:
35. Etude relative aux coûts poten
show all

Assurance de qualité pour le cancer rectal – phase 2 ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?